617 related articles for article (PubMed ID: 20054273)
21. Venous thromboembolism risk and prophylaxis in the acute hospital care setting-results of the Endorse study in Tunisia.
Jerbi Z; Houman MH; Ghedira H; Kamoun S; Ben Salah A
Tunis Med; 2011 Oct; 89(10):784-9. PubMed ID: 22076903
[TBL] [Abstract][Full Text] [Related]
22. Perioperative venous thromboembolism prophylaxis in Israel: a survey of academic surgical departments.
Ellis MH; Elis A
Eur J Haematol; 2004 Aug; 73(2):104-8. PubMed ID: 15245509
[TBL] [Abstract][Full Text] [Related]
23. Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis.
Shorr AF; Kwong LM; Sarnes M; Happe L; Farrelly E; Mody-Patel N
Thromb Res; 2007; 121(1):17-24. PubMed ID: 17449088
[TBL] [Abstract][Full Text] [Related]
24. Venous thromboembolism prophylaxis for surgical patients in an Asian hospital.
Tan LH; Tan SC
ANZ J Surg; 2004 Jun; 74(6):455-9. PubMed ID: 15191481
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the duration of thromboembolic prophylaxis after high-risk orthopaedic surgery: the ETHOS observational study.
Bergqvist D; Arcelus JI; Felicissimo P;
Thromb Haemost; 2012 Feb; 107(2):270-9. PubMed ID: 22186708
[TBL] [Abstract][Full Text] [Related]
26. Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study.
Scannapieco G; Ageno W; Airoldi A; Bonizzoni E; Campanini M; Gussoni G; Silingardi M; Valerio A; Zilli C; Iori I;
Thromb Haemost; 2010 Oct; 104(4):734-40. PubMed ID: 20664897
[TBL] [Abstract][Full Text] [Related]
27. Risk stratification and utilisation of thrombo-embolism prophylaxis in a medical-surgical ICU: a hospital-based study.
Ansari K; Dalal K; Patel M
J Indian Med Assoc; 2007 Sep; 105(9):536, 538, 540 passim. PubMed ID: 18338482
[TBL] [Abstract][Full Text] [Related]
28. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
29. Rates of venous thromboembolism occurrence in medical patients among the insured population.
Spyropoulos AC; Hussein M; Lin J; Battleman D
Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
[TBL] [Abstract][Full Text] [Related]
30. The ''critical thrombosis period'' in major orthopedic surgery: when to start and when to stop prophylaxis.
Warwick D; Rosencher N
Clin Appl Thromb Hemost; 2010 Aug; 16(4):394-405. PubMed ID: 20019020
[TBL] [Abstract][Full Text] [Related]
31. A cross-sectional evaluation of venous thromboembolism risk and use of venous thromboembolism prophylaxis in hospitalized patients in Senegal.
Bâ SA; Badiane SB; Diop SN; Diouf FS; Fall D; Ka MM; Kane A; Ndiaye M;
Arch Cardiovasc Dis; 2011 Oct; 104(10):493-501. PubMed ID: 22044701
[TBL] [Abstract][Full Text] [Related]
32. In-hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study.
Gussoni G; Campanini M; Silingardi M; Scannapieco G; Mazzone A; Magni G; Valerio A; Iori I; Ageno W;
Thromb Haemost; 2009 May; 101(5):893-901. PubMed ID: 19404543
[TBL] [Abstract][Full Text] [Related]
33. Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study.
Rogers SO; Kilaru RK; Hosokawa P; Henderson WG; Zinner MJ; Khuri SF
J Am Coll Surg; 2007 Jun; 204(6):1211-21. PubMed ID: 17544079
[TBL] [Abstract][Full Text] [Related]
34. [Venous thromboembolism prophylaxis in Colombian surgical and medical patients: results for Colombia of the ENDORSE study].
Dennis RJ; Roa JH; Villadiego J; Méndez F; Vieda E; Restrepo H
Biomedica; 2011 Jun; 31(2):200-8. PubMed ID: 22159536
[TBL] [Abstract][Full Text] [Related]
35. Thromboprophylaxis in orthopedic surgery: how long is long enough?
Muntz J
Am J Orthop (Belle Mead NJ); 2009 Aug; 38(8):394-401. PubMed ID: 19809604
[TBL] [Abstract][Full Text] [Related]
36. Assessing the quality of pharmacological treatments from administrative databases: the case of low-molecular-weight heparin after major orthopaedic surgery.
Gerkens S; Beguin C; Crott R; Closon MC; Horsmans Y
J Eval Clin Pract; 2008 Aug; 14(4):585-94. PubMed ID: 18462276
[TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolism risk and prophylaxis in the acute hospital care setting: the Irish results of the ENDORSE study.
Murphy O; O'Connell O; Liston R; Connaughton J; Costello R; Breiden J; Doran P; Gaine S
Ir Med J; 2012 May; 105(5):140-3. PubMed ID: 22803491
[TBL] [Abstract][Full Text] [Related]
38. High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis.
Baba-Ahmed M; Le Gal G; Couturaud F; Lacut K; Oger E; Leroyer C
Thromb Haemost; 2007 Feb; 97(2):171-5. PubMed ID: 17264942
[TBL] [Abstract][Full Text] [Related]
39. Venous thromboembolism prophylaxis in hospitalized heart failure patients.
Jois-Bilowich P; Michota F; Bartholomew JR; Glauser J; Diercks D; Weber J; Fonarow GC; Emerman CL; Peacock WF;
J Card Fail; 2008 Mar; 14(2):127-32. PubMed ID: 18325459
[TBL] [Abstract][Full Text] [Related]
40. Appropriate thromboprophylaxis in hospitalized cancer patients.
Amin A; Stemkowski S; Lin J; Yang G
Clin Adv Hematol Oncol; 2008 Dec; 6(12):910-20. PubMed ID: 19209141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
